Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Compare retirement index funds to see which has the lowest fees while meeting your risk and diversification goals.
28,038 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
CME Group moves Bitcoin futures to 24/7 trading, a milestone that could shrink the once persistent CME gaps. Traders ...
Cerebras Systems’ IPO surge has cooled, steering investors toward Alibaba as a more scalable AI platform. This report...
A CNBC analyst contends the FedEx selloff reflects misinterpretation of the income statement, not a collapse in deman...
Ethereum co-founder Vitalik Buterin escalated ETH sales as prices retreat. On-chain data show 1,869 ETH sold for abou...
Jeff Bezos publicly challenged Elon Musk's plan for space-based data centers, calling the proposed timeline likely to...
Artificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
ServiceNow has faced a brutal market sell-off in 2026. This guide breaks down whether the decline creates a compellin...
Hyperliquid’s HYPE token surged past $60, signaling a shift toward an on-chain Wall Street platform as institutions e...
Rising memory costs are pushing Apple to raise prices higher. This article examines how that could affect margins, de...
Meta Platforms is negotiating a landmark AI hardware pact with AMD that could top $100 billion, including an option f...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...